Janone Inc. (NASDAQ:ALTS) Sees Significant Decline in Short Interest

Janone Inc. (NASDAQ:ALTS) was the target of a large drop in short interest in December. As of December 31st, there was short interest totalling 62,900 shares, a drop of 50.4% from the December 15th total of 126,700 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average trading volume of 198,900 shares, the days-to-cover ratio is presently 0.3 days.

Janone Stock Down 10.0 %

Shares of Janone stock opened at $5.69 on Tuesday. Janone has a 12-month low of $0.50 and a 12-month high of $7.09. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 1.96. The stock’s fifty day moving average is $3.54.

About Janone

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.